Cargando…

The P2Y12 Receptor Antagonist Selatogrel Dissolves Preformed Platelet Thrombi In Vivo

Selatogrel, a potent and reversible antagonist of the P2Y12 receptor, inhibited FeCl(3)-induced thrombosis in rats. Here, we report the anti-thrombotic effect of selatogrel after subcutaneous applications in guinea pigs and mice. Selatogrel inhibited platelet function only 10 min after subcutaneous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crescence, Lydie, Kramberg, Markus, Baumann, Martine, Rey, Markus, Roux, Sebastien, Panicot-Dubois, Laurence, Dubois, Christophe, Riederer, Markus A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619398/ https://www.ncbi.nlm.nih.gov/pubmed/34830631 http://dx.doi.org/10.3390/jcm10225349

Ejemplares similares

P1639: PLATELET-EDUCATED CANCER CELLS OVEREXPRESS FIBRONECTIN AS WELL AS DIFFERENT GLYCOSYLTRANSFERASES.
por: Langiu, Mélanie, et al.
Publicado: (2023)

Oral Squamous Cell Carcinoma Is Associated with a Low Thrombosis Risk Due to Storage Pool Deficiency in Platelets
por: Haen, Pierre, et al.
Publicado: (2021)

Impacts of Cancer on Platelet Production, Activation and Education and Mechanisms of Cancer-Associated Thrombosis
por: Plantureux, Léa, et al.
Publicado: (2018)

Platelets, Thrombo-Inflammation, and Cancer: Collaborating With the Enemy
por: Palacios-Acedo, Ana Luisa, et al.
Publicado: (2019)

Role of Neutrophils and NETs in Animal Models of Thrombosis
por: Carminita, Estelle, et al.
Publicado: (2022)

Platelet and Cancer-Cell Interactions Modulate Cancer-Associated Thrombosis Risk in Different Cancer Types
por: Palacios-Acedo, Ana-Luisa, et al.
Publicado: (2022)

P1644: ADP-DEPENDENT PLATELET ACTIVATION IS IMPORTANT IN THE DEVELOPMENT OF VENOUS THROMBOSIS DURING A LONG-DISTANCE FLIGHT
por: Tourn, Julie, et al.
Publicado: (2023)

Thrombosis Risk Associated with Head and Neck Cancer: A Review
por: Haen, Pierre, et al.
Publicado: (2019)

P2RY12-Inhibitors Reduce Cancer-Associated Thrombosis and Tumor Growth in Pancreatic Cancers
por: Palacios-Acedo, Ana Luisa, et al.
Publicado: (2021)

Neutrophils, Cancer and Thrombosis: The New Bermuda Triangle in Cancer Research
por: Langiu, Mélanie, et al.
Publicado: (2022)

Comparison of the effects of the GPIIb-IIIa antagonist Zalunfiban and the P2Y12 antagonist Selatogrel on Platelet Aggregation
por: Curry, Benjamin J., et al.
Publicado: (2023)

The reversible P2Y(12) antagonist ACT‐246475 causes significantly less blood loss than ticagrelor at equivalent antithrombotic efficacy in rat
por: Rey, Markus, et al.
Publicado: (2017)

Fibrin-bearing microparticles: marker of thrombo-embolic events in pancreatic and colorectal cancers
por: Mege, Diane, et al.
Publicado: (2017)

Increased levels of the megakaryocyte and platelet expressed cysteine proteases stefin A and cystatin A prevent thrombosis
por: Mezzapesa, Anna, et al.
Publicado: (2019)

Assessment of Thrombotic and Bleeding Tendency in Two Mouse Models of Chronic Kidney Disease: Adenine-Diet and 5/6th Nephrectomy
por: Makhloufi, Camélia, et al.
Publicado: (2020)

Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of the P2Y12 receptor antagonist selatogrel
por: Schilling, Uta, et al.
Publicado: (2022)

Mind the Gap: Model-Based Switching from Selatogrel to Maintenance Therapy with Oral P2Y12 Receptor Antagonists
por: Hsin, Chih-hsuan, et al.
Publicado: (2023)

Fibrinolysis in Platelet Thrombi
por: Kanji, Rahim, et al.
Publicado: (2021)

Mechanisms of cancer-associated thrombosis
por: Mege, Diane, et al.
Publicado: (2019)

Pharmacokinetic/pharmacodynamic modeling of drug interactions at the P2Y(12) receptor between selatogrel and oral P2Y(12) antagonists
por: Henrich, Andrea, et al.
Publicado: (2021)

Reversal of stress fibre formation by Nitric Oxide mediated RhoA inhibition leads to reduction in the height of preformed thrombi
por: Atkinson, L., et al.
Publicado: (2018)

Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y(12) receptor antagonist, in patients with chronic coronary syndromes
por: Storey, Robert F, et al.
Publicado: (2019)

Effect of Rifampin‐Mediated OATP1B1 and OATP1B3 Transporter Inhibition on the Pharmacokinetics of the P2Y12 Receptor Antagonist Selatogrel
por: Schilling, Uta, et al.
Publicado: (2020)

Cancer cell–derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo
por: Thomas, Grace M., et al.
Publicado: (2009)

An OMA1 redox site controls mitochondrial homeostasis, sarcoma growth, and immunogenicity
por: Miallot, Richard, et al.
Publicado: (2023)

Effects of different shear rates on the attachment and detachment of platelet thrombi
por: SHI, XIAOFENG, et al.
Publicado: (2016)

Abnormal Whole Blood Thrombi in Humans with Inherited Platelet Receptor Defects
por: Castellino, Francis J., et al.
Publicado: (2012)

Antagonistic Roles of Human Platelet Integrin αIIbβ3 and Chemokines in Regulating Neutrophil Activation and Fate on Arterial Thrombi Under Flow
por: Schönichen, Claudia, et al.
Publicado: (2023)

DNA methylation signatures follow preformed chromatin compartments in cardiac myocytes
por: Nothjunge, Stephan, et al.
Publicado: (2017)

Contribution of neutrophil elastase to the lysis of obliterative thrombi in the context of their platelet and fibrin content
por: Rábai, Gyöngyi, et al.
Publicado: (2010)

Platelet–Neutrophil Association in NETs-Rich Areas in the Retrieved AIS Patient Thrombi
por: Pir, Ghulam Jeelani, et al.
Publicado: (2022)

Acute Thrombocytopenic Purpura with Platelet Thrombi in Small Blood Vessels: Report of a Case
por: Epstein, Franklin H., et al.
Publicado: (1948)

Preparation of Preformed Iodixanol Gradients
por: Graham, John
Publicado: (2002)

Absence of early platelet increment in healthy mice during decitabine treatment
por: Baumann, Juliane, et al.
Publicado: (2022)

Vascular Effects of Endothelin Receptor Antagonists Depends on Their Selectivity for ET(A) Versus ET(B) Receptors and on the Functionality of Endothelial ET(B) Receptors
por: Iglarz, Marc, et al.
Publicado: (2015)

Pulmonary platelet thrombi and vascular pathology in acute chest syndrome in patients with sickle cell disease
por: Anea, Ciprian B., et al.
Publicado: (2016)

EWVDV-Mediated Platelet-Targeting Nanoparticles for the Multimodal Imaging of Thrombi at Different Blood Flow Velocities
por: Xu, Jie, et al.
Publicado: (2020)

Nearly all left atrial thrombi may be extended from pulmonary vein thrombi
por: Takeuchi, Hidekazu
Publicado: (2015)

Modeling α-Synucleinopathy in Organotypic Brain Slice Culture with Preformed α-Synuclein Amyloid Fibrils
por: Roux, Amandine, et al.
Publicado: (2020)

The Clip-Segment of the von Willebrand Domain 1 of the BMP Modulator Protein Crossveinless 2 Is Preformed
por: Fiebig, Juliane E., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g94kh3uoqacaaa6o151c63v3ft